Post COVID-19 Biorepository

Launched by UNIVERSITY OF KANSAS MEDICAL CENTER · May 11, 2021

Keywords

ClinConnect Summary

This clinical trial, called the Post COVID-19 Biorepository, is focused on understanding the long-term effects of COVID-19. Researchers are collecting samples and health information from patients who have previously tested positive for the virus and are receiving follow-up care. The goal is to create a valuable resource that includes clinical data and medical images to help advance research on COVID-19 and its impacts on health.

To participate in this study, you need to be at least 18 years old and have a confirmed diagnosis of COVID-19, either through a test or antibody results. You must also be a patient at TUKHS or taking part in another approved study. If you choose to join, you will help researchers gather important information that could improve understanding and treatment of COVID-19. Remember, participation is entirely voluntary, and you can ask questions or decline if you feel uncomfortable.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. The participant is a patient at TUKHS or has agreed to participate in a study approved by the KUMC Human Research Protection Program (HRPP).
• • 2. The participant has a previous diagnosis of COVID-19 confirmed by COVID-19 PCR or antibody testing and is being seen for outpatient follow-up.
• • 3. Patient is ≥ 18 years of age or older.
• Exclusion Criteria:
• • 1. Participant declines to participate.
• • 2. Participant or healthcare surrogate is unable to provide informed consent.